APA (7th ed.) Citation

Spoelstra, S. K., Bruins, J., Bais, L., Seerden, P., Castelein, S., & Knegtering, H. (2022). One-Month versus Three-Month Formulation of Paliperidone Palmitate Treatment in Psychotic Disorders: Patients', Relatives', and Mental Health Professionals' Perspectives. Patient Preference & Adherence, 16, 615. https://doi.org/10.2147/PPA.S349460

Chicago Style (17th ed.) Citation

Spoelstra, S Kor, Jojanneke Bruins, Leonie Bais, Paul Seerden, Stynke Castelein, and Henderikus Knegtering. "One-Month Versus Three-Month Formulation of Paliperidone Palmitate Treatment in Psychotic Disorders: Patients', Relatives', and Mental Health Professionals' Perspectives." Patient Preference & Adherence 16 (2022): 615. https://doi.org/10.2147/PPA.S349460.

MLA (9th ed.) Citation

Spoelstra, S Kor, et al. "One-Month Versus Three-Month Formulation of Paliperidone Palmitate Treatment in Psychotic Disorders: Patients', Relatives', and Mental Health Professionals' Perspectives." Patient Preference & Adherence, vol. 16, 2022, p. 615, https://doi.org/10.2147/PPA.S349460.